Skip to content
  • HARMONY
    • HARMONY Home
    • Cervical Cancer
      • Cervical Cancer Learning Center
      • Cervical Cancer: A Preventable Global Threat
      • History of HPV Vaccines and Screening
    • HARMONY Resources
  • Fellows Programs
    • Society for Translational Oncology Fellowship (STOF)
    • Legacy Fellows Programs
      • Fellows’ Forum
      • STO-CSCO International Fellowship Program
      • Advanced Clinical Trial Workshops in China (ACT China)
  • Voices in Oncology
    • Insights & Perspectives
    • Podcast
    • Blog
  • Educational Programs
    • CME Mission and Accreditation
      • Accreditation Policies
    • Legacy Educational Programs
      • Incorporating Molecular Testing to Support Personalized Cancer Care
      • Addressing Racial Disparities in Cancer Care
      • Cancer A Looming Public Health Crisis in Africa: A Call to Accelerate Equitable Access to Medicines​
      • Molecular and Precision Medicine (MAP) Series
      • Chabner Colloquium
      • STO Annual Meeting
      • STO-CSCO Joint Symposium
      • European Cancer Concord
      • Pinedo Cancer Care Prize
    • Video Library
  • About Us
    • Mission
    • Leadership
      • Board of Directors
      • Mission Advisory Board
      • Education Council
      • Our Team
    • Newsletters
    • Press Releases
    • Journal CME Records Request
  • HARMONY
    • HARMONY Home
    • Cervical Cancer
      • Cervical Cancer Learning Center
      • Cervical Cancer: A Preventable Global Threat
      • History of HPV Vaccines and Screening
    • HARMONY Resources
  • Fellows Programs
    • Society for Translational Oncology Fellowship (STOF)
    • Legacy Fellows Programs
      • Fellows’ Forum
      • STO-CSCO International Fellowship Program
      • Advanced Clinical Trial Workshops in China (ACT China)
  • Voices in Oncology
    • Insights & Perspectives
    • Podcast
    • Blog
  • Educational Programs
    • CME Mission and Accreditation
      • Accreditation Policies
    • Legacy Educational Programs
      • Incorporating Molecular Testing to Support Personalized Cancer Care
      • Addressing Racial Disparities in Cancer Care
      • Cancer A Looming Public Health Crisis in Africa: A Call to Accelerate Equitable Access to Medicines​
      • Molecular and Precision Medicine (MAP) Series
      • Chabner Colloquium
      • STO Annual Meeting
      • STO-CSCO Joint Symposium
      • European Cancer Concord
      • Pinedo Cancer Care Prize
    • Video Library
  • About Us
    • Mission
    • Leadership
      • Board of Directors
      • Mission Advisory Board
      • Education Council
      • Our Team
    • Newsletters
    • Press Releases
    • Journal CME Records Request

HARMONY Logo

Newsletters

Subscribe to our Newsletter
  • Feb 21, 2025
  • Newsletters

Understanding Cancer Prevention, Risk Factors, and Early Detection

  • Jan 23, 2025
  • Newsletters

Addressing the Cervical Cancer Crisis

  • Dec 12, 2024
  • Newsletters

The Monthly: Last chance to earn CME credit in 2024

  • Nov 15, 2024
  • Newsletters

Cervical Cancer- A Global Concern

  • Oct 17, 2024
  • Newsletters

Overcoming Barriers to Equity in Cancer Care

10/24 Newsletter
  • Sep 19, 2024
  • Newsletters

Incorporating Molecular Testing and Latest Advances

Image of September newsletter featuring new educational activities
  • Aug 15, 2024
  • Newsletters

Explore the Highly Cited Collection in The Oncologist

August 2024 Newsletter
  • Jul 18, 2024
  • Newsletters

Global Experts Unite to Tackle Cancer Crisis in Africa

July 2024 Newsletter
  • Jun 13, 2024
  • Newsletters

Enhancing Informed Consent for Better Clinical Trial Data Sharing

June 2024 NL
Prev
1 2 3 4
Next

HARMONY is STO’s flagship program designed to support the Society’s mission of advancing oncology education, translational research, and equitable cancer care through global collaborations within its Cervical Cancer Collective.

 

The Society for Translational Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Society for Translational Oncology (STO) is a 501(c)(3) not-for-profit organization.
EIN: 20-3186261
Terms of Use | Privacy Policy | Contact Us
Copyright © 2026 Society for Translational Oncology